U.S. Life Sciences Stock News

On August 20, 2025, Huntington Ingalls Industries (HII) announced that its Mission Technologies division is among the companies awarded a multiple award contract, with a ceiling of US$267 million, to provide training products and services to enhance U.S. Navy fleet readiness. This award enables HII to compete for substantial task orders in supporting the Navy’s professional development, including delivering digital curriculum and on-demand learning solutions crucial for adapting to evolving...

In the past week, Fidelity National Information Services (FIS) introduced its Optimized Reconciliation Service and Investor Services Suite, both designed to automate and enhance operations for banks, fund managers, and financial institutions through advanced digitized workflows. These product launches highlight the growing risks and costs of operational inefficiencies, illustrated by FIS research citing an average US$98.5 million in annual business losses, and respond to industry demand for...

Certainly! Here is the revised article text with em dashes removed and the formatting improved: If you are weighing what to do next with Nutanix stock, you are in good company. Many investors are closely watching this name as it continues to move in intriguing ways. Over the past year, Nutanix has notched a total return of 30.8%, far outpacing the S&P 500 and catching the attention of both growth seekers and value hunters. The stock has seen some volatility recently, with returns slipping a...

In June 2025, The J.M. Smucker Company disclosed significant impairment charges tied to its Hostess Brands acquisition and revised its sales forecasts downward for the Sweet Baked Snacks segment, prompting investigations by several law firms into possible securities law violations and business practices. This scrutiny raises questions about whether the company misrepresented the potential benefits of the Hostess acquisition or delayed acknowledging losses, contributing to increased legal and...

Thinking about what to do with fuboTV stock? You are not alone. Investors have watched this streaming-focused player deliver some rollercoaster returns lately. Over just the past year, FUBO rocketed up more than 66% in total return. Zoom out, though, and you will see a stock that has lost ground over three and five years. This underscores just how volatile the journey has been. Recently, after some short-term pop, the stock has pulled back a bit, reminding everyone that big price swings are...

NYSE:KEYS 1 Year Share Price vs Fair Value Explore Keysight Technologies's Fair Values from the Community and select...

Humana (HUM) has been under the spotlight recently after a quick rebound in its stock price over the past month. Although there has not been a single headline-grabbing event to explain the momentum, the move is raising eyebrows for investors who may be considering whether to participate in this rally or wait on the sidelines. When a large healthcare company’s shares gain nearly 30% in a single month without dramatic news, it can signal a shift in market sentiment. This may reflect an...

If you’re wondering what to do with Collegium Pharmaceutical (COLL) in light of their latest earnings report, you’re not alone. The company just posted its second quarter numbers, revealing a drop in earnings compared to last year, but also surprised many by raising its full year revenue guidance. In addition, Collegium provided an update on its aggressive share buyback program, which could speak volumes about management’s confidence or at least their current preferred use of cash. These...

Becton, Dickinson and Company recently reported third quarter results showing year-over-year increases in sales and net income, while also raising its full-year revenue growth guidance for 2025 to a range of 8.2% to 8.7%. An interesting aspect is that despite strong financial performance, the company did not repurchase any shares in the most recent quarter, having already completed its previously announced buyback program. With the company's raised revenue growth guidance, we'll assess how...

Thinking about what to do with DoorDash stock right now? You are definitely not alone. Whether you have been riding the wave for the past year or are just peeking at the ticker for the first time, there is no denying that DoorDash has been on the move. In the past year, the stock has nearly doubled, delivering a massive 88% total return. The past three months alone have seen a 21% jump, which is remarkable momentum for a company that is already a household name in food delivery. The energy...

Earlier this month, Establishment Labs Holdings raised its 2025 revenue guidance to a range of US$208 million to US$212 million and reported second-quarter sales of US$51.3 million, up from US$44.12 million a year prior. An interesting aspect is the company's forecast of at least US$40 million in US Motiva revenue for the year, marking the growing importance of its US operations in total sales. We'll explore how the stronger full-year revenue outlook and US Motiva momentum could influence...

If you’ve been tracking Brookfield Business (NYSE:BBUC), the recent renewal of its normal course issuer bids for both limited partnership units and class A exchangeable subordinate voting shares probably caught your eye. Management is sending a clear message about their confidence in the firm’s intrinsic value, especially with buyback programs often interpreted as a commitment to shareholder returns. The regulatory filings released alongside this move suggest Brookfield is focused on capital...

ServiceNow (NYSE:NOW) recently caught investor attention after shares bounced nearly 4% in the past week, shrugging off some month-long pressure that saw the stock dip about 7%. There has been no single headline catalyst driving this latest move. With ServiceNow’s valuation already a subject of debate, even modest volatility prompts a closer look. When a tech leader like this changes direction, it naturally raises questions about what could be next for the price and whether this is a good...

EOG Resources reported its second-quarter earnings, showing year-over-year declines in both revenue and net income, and also released updated production guidance for the upcoming quarter and full year. Despite lower financial results, the company completed a US$600 million share buyback this quarter, bringing total repurchases to over US$5.57 billion under its current program. We'll examine how EOG Resources' updated production outlook informs the company's investment narrative and...

Premialab recently announced a partnership with Nasdaq eVestment™, integrating their data analytics platforms to provide institutional investors with enhanced tools for strategy analysis, portfolio construction, and risk monitoring. This collaboration gives users seamless access to expansive datasets and proprietary quantitative indices, streamlining research workflows and supporting comprehensive investment insights within a unified environment. We'll explore how the expanded analytical...

NasdaqCM:UBXG 1 Year Share Price vs Fair Value Explore U-BX Technology's Fair Values from the Community and select...

NasdaqCM:LFVN 1 Year Share Price vs Fair Value Explore LifeVantage's Fair Values from the Community and select yours...

If you own a piece of Royal Caribbean Cruises (RCL) or have been eyeing its stock, the recent moves might have left you wondering what’s next. While there hasn’t been a specific headline moving the stock this week, the shares have drifted a bit, catching the attention of investors focused on valuation and future growth. Sometimes, a quiet period can reflect investor sentiment as much as major news, and with RCL now sitting at $329.12, it may be a good time to look beneath the...

Trying to figure out what to do with TKO Group Holdings stock right now? You are not alone. With some eye-catching moves in recent months, investors are wondering if the stock's rapid momentum really reflects deeper value or just market excitement. Over the past year, TKO has delivered an impressive 53% total return, with especially strong gains in the last 30 days (over 8%) and nearly 17% in the last quarter alone. After a brief dip this week, the stock is still comfortably above its...

Certainly! Here is the revised article text with em dashes replaced and formatting improved: If you have been watching Medtronic (MDT) lately, you might have noticed the stir from its latest boardroom shake-up. Just this week, Medtronic announced it is expanding its board and forming two new oversight committees, following productive engagement with activist investor Elliott Investment Management. These moves, which include adding leaders with fresh medical device expertise, are intended to...

BGC Group, Inc. recently announced a fixed-income exchange offer for its US$700 million 6.150% senior unsecured notes due 2030, allowing investors to exchange their existing bonds under new terms. This move reflects BGC Group’s efforts to actively manage its debt profile, signaling a focus on improving financial flexibility and extending debt maturities. We’ll explore how BGC’s exchange offer for its senior notes could impact the company’s investment outlook and future growth plans. Uncover...

CompoSecure announced its second quarter and six-month 2025 earnings, reporting a net loss of US$26.13 million for the quarter and US$4.63 million for the half-year, alongside a sharp drop in sales compared to the prior year. For both periods, the company moved from profitability to loss and experienced a significant decrease in basic and diluted earnings per share, marking a sharp year-over-year downturn in financial performance. Given these unexpected losses and reduced sales, we’ll assess...

Certainly! Here’s the revised article with em dashes removed and rephrased for clarity: So, you are thinking about what to do with MercadoLibre’s stock right now. Maybe you already own shares and are debating whether to hold or trim, or perhaps you are wondering if this is the right moment to jump in. Either way, MercadoLibre has likely caught your attention for good reason. Over the past year, the Latin American e-commerce leader has not only outperformed many of its peers but has also...

Trying to Decide What to Do With Thermo Fisher Scientific Stock? Let’s talk about where Thermo Fisher Scientific sits right now, especially if you’ve been weighing whether to buy, hold, or step back for a while. The stock price is fresh off some interesting moves. After dropping over 18% in the last year, TMO has posted a strong comeback in recent weeks, gaining nearly 24% over the past three months and 22% in the last 30 days. Even just in the last week, shares ticked up by over 2%. Clearly,...